Kimberly Blackwell - Chief Development Officer @ Nucleus RadioPharma

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title Chief Development Officer
Primary Organization
Nucleus RadioPharma

Location Denver, Colorado, United States
Regions Greater Denver Area, Western US
Gender Female
Also Known As Kim Blackwell

Investor Type
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn

Kimberly Blackwell is based out of Denver, Colorado and is the Chief Development Officer of Nucleus RadioPharma and also serves as `a Board Member for Incyclix Bio. Kimberly previously worked at Zentalis Pharmaceuticals as a Chief Executive Officer and Board Member. Kimberly Blackwell attended the Duke University.

Personal Investments

Number of Investments

Kimberly Blackwell

invested in

MoonPay

obfuscation

. This investment -

Series A - MoonPay

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	MoonPay	—	Series A - MoonPay	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Kimberly Blackwell

has

current jobs as

Chief Development Officer

Nucleus RadioPharma

and

Co-Founder

Cereius

. Additionally,

Kimberly Blackwell

has had

past jobs including

Chief Executive Officer

Zentalis Pharmaceuticals

Nucleus RadioPharma Chief Development Officer
Cereius Co-Founder

Organization Name	Title At Company	Start Date	End Date
Zentalis Pharmaceuticals	Chief Executive Officer	May 2022	Nov 2024
Tempus	Chief Medical Officer and SVP, Clinical Oncology Development	2020	2022
Duke Cancer Institute	Assistant Prof. of Radiation Oncology	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Kimberly Blackwell

holds

board and advisor roles as

Board Member

Incyclix Bio

and

Non-Executive Director

CHARM Therapeutics

Incyclix Bio Board MemberDec 17, 2025
CHARM Therapeutics Non-Executive DirectorSep 2025

Organization Name	Title At Company	Start Date	End Date
Zentalis Pharmaceuticals	Board Member	May 2022	Nov 2024

Related Hubs

Hub Name	CB Rank (Hub)
United States Private Equity Stage Companies With Fewer Than 1000 Employees	15,148
United States Private Equity Stage Companies With More Than 10 Employees	13,458
Health Care Companies With Fewer Than 100 Employees (Top 10K)	607
Health Care Companies With More Than 10 Employees (Top 10K)	477
United States Private Equity Stage Companies With Fewer Than 100 Employees	22,516
United States Health Care Companies (Top 10K)	480
AstraZeneca Portfolio Companies	89,758
United States Private Equity Stage Companies	11,129
OrbiMed Portfolio Companies	59,408
Health Care Private Equity Stage Companies With More Than 50 Employees	27,670